SCA Pharmaceuticals, Inc. has recalled 654 bags of Vasopressin (20 Units added to 0.9% Sodium Chloride 100 mL). This prescription medication is being recalled because it was found to be subpotent, meaning it may not contain the full required strength of the active drug. Because this is a critical medication often used to manage blood pressure in hospital settings, a dose that is weaker than expected could lead to ineffective treatment of serious medical conditions. If you or a loved one were administered this product in a clinical setting between December 2020 and January 2021, you should be aware of this quality issue.
The drug is subpotent, which means it may fail to provide the intended therapeutic effect. In clinical situations where vasopressin is used, such as for blood pressure support, an under-strength dose could result in poor patient outcomes or medical emergencies not being adequately controlled.
Drug recall remedy for subpotent medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.